Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

NCT00100581 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis C

Interventions

DRUG: Efavirenz
DRUG: Lamivudine
DRUG: Lopinavir/ritonavir
DRUG: Pegylated interferon alfa-2a
DRUG: Ribavirin
DRUG: Tenofovir disoproxil fumarate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)